These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18257463)

  • 41. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study.
    Jackson ML; Nelson JC; Chen RT; Davis RL; Jackson LA;
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):790-6. PubMed ID: 17286320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice.
    Onundarson PT; Einarsdottir KA; Gudmundsdottir BR
    Int J Lab Hematol; 2008 Oct; 30(5):382-9. PubMed ID: 19046313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation.
    Marco F; Gutiérrez JI; Orkolaga K; Márquez JA; Ojínaga MJ; de Zárate IO; de Heredia JM
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):509-12. PubMed ID: 16905959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemostatic management of tooth extractions in patients on oral antithrombotic therapy.
    Morimoto Y; Niwa H; Minematsu K
    J Oral Maxillofac Surg; 2008 Jan; 66(1):51-7. PubMed ID: 18083415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin.
    Evans M; Lewis GM
    Pharmacotherapy; 2005 Nov; 25(11):1656-9. PubMed ID: 16232028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does heart failure exacerbation increase response to warfarin? A critical review of the literature.
    Self TH; Reaves AB; Oliphant CS; Sands C
    Curr Med Res Opin; 2006 Nov; 22(11):2089-94. PubMed ID: 17076968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.
    Wright DH; Herman GA; Maes A; Liu Q; Johnson-Levonas AO; Wagner JA
    J Clin Pharmacol; 2009 Oct; 49(10):1157-67. PubMed ID: 19783710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between warfarin and cranberry juice.
    Paeng CH; Sprague M; Jackevicius CA
    Clin Ther; 2007 Aug; 29(8):1730-5. PubMed ID: 17919554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrice weekly warfarin administration in haemodialysis patients.
    Sood MM; Rigatto C; Bueti J; Lang C; Miller L; PonnamPalam A; Reslerova M; Sood A; Komenda P
    Nephrol Dial Transplant; 2009 Oct; 24(10):3162-7. PubMed ID: 19487735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of the potential drug interaction between warfarin and levothyroxine.
    Wood MD; Delate T; Clark M; Clark N; Horn JR; Witt DM
    J Thromb Haemost; 2014 Aug; 12(8):1313-9. PubMed ID: 24913218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacodynamics of uniform versus nonuniform warfarin dosages.
    Hameed MS; Nafziger AN; Gartung AM; Bertino JS
    Pharmacotherapy; 2008 Jun; 28(6):707-11. PubMed ID: 18503398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preinjury warfarin worsens outcome in elderly patients who fall from standing.
    Howard JL; Cipolle MD; Horvat SA; Sabella VM; Reed JF; Fulda G; Tinkoff G; Pasquale MD
    J Trauma; 2009 Jun; 66(6):1518-22; discussion 1523-4. PubMed ID: 19509609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP.
    Lee SB; Manno EM; Layton KF; Wijdicks EF
    Neurology; 2006 Oct; 67(7):1272-4. PubMed ID: 17030765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Educational role of community nurse in care of patients treated with oral anticoagulation therapy].
    Sawicka-Powierza J; Ołtarzewska AM; Chlabicz S; Rogowska-Szadkowska D; Marcinowicz L
    Pol Merkur Lekarski; 2009 Jun; 26(156):636-9. PubMed ID: 19711731
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probable warfarin-simvastatin interaction.
    Westergren T; Johansson P; Molden E
    Ann Pharmacother; 2007 Jul; 41(7):1292-5. PubMed ID: 17565042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
    Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
    Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
    Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Monitoring age-dependent effect of anticoagulation treatment in patients with atrial fibrillation].
    Hnátek T; Zogala D; Kameník L; Kotík I; Jerábek I; Zavoral M
    Vnitr Lek; 2008 Jan; 54(1):21-4. PubMed ID: 18390113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.